ArticleRwanda journal of medicine and health sciences2022
Pharmacovigilance: Awareness and Practice of Nurses and Midwives in Monitoring and Reporting Adverse Drug Reactions in a Selected University Teaching Hospital, Rwanda.
Article in Rwanda journal of medicine and health sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Adverse drug reactions result in thousands of deaths, disabilities, and other serious outcomes. Nurses and midwives administer drugs, monitor both therapeutic and adverse drug reactions, and are on the front line of safety reporting. This study aimed to assess awareness of nurses and midwives about pharmacovigilance and their practice in monitoring and reporting adverse drug reactions at the University Teaching Hospital of Kigali. Methods: We conducted a cross-sectional study on 147 randomly selected nurses and midwives. Self-administered questionnaires were used to collect data. We analyzed data using SPSS version 22 computer software for descriptive and inferential statistics. Results: Concerning the awareness of nurses and midwives, 88% had heard about pharmacovigilance, and 22.3% were aware of Rwanda Food and Drug Authority. Nearly two-thirds (62.3%) reported inadequate practice in monitoring adverse drug reactions. Their practice was associated with having heard about pharmacovigilance (p=0.004) and knowing the hospital's adverse drug reactions reporting system (p=0.005). Concerning practice in reporting adverse drug reactions, 66.2% had observed adverse drug reactions, and 18.2% filled out adverse event notification forms. Conclusion: Few nurses and midwives were aware of the pharmacovigilance system in Rwanda, and many of them reported inadequate practices toward monitoring and reporting adverse drug reactions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.